Page last updated: 2024-11-13

lithium orotate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID23686432
SCHEMBL ID161884
MeSH IDM0066623

Synonyms (15)

Synonym
einecs 226-081-4
l2n7z24b30 ,
unii-l2n7z24b30
lithium 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate
4-pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-, monolithium salt
5266-20-6
4-pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-, lithium salt (1:1)
lithium orotate
SCHEMBL161884
lithium orotate [who-dd]
lithium orotate [vandf]
DTXSID9063748
lithium 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate
Q6647963
lithium;2,4-dioxo-1h-pyrimidine-6-carboxylate

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Intriguingly, lithium orotate (LiOr) is suggested to possess unique uptake characteristics that would allow for reduced dosing and mitigation of toxicity concerns."( Different pharmacokinetics of lithium orotate inform why it is more potent, effective, and less toxic than lithium carbonate in a mouse model of mania.
Bekar, LK; Pacholko, AG, 2023
)
1.55
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's2 (33.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 55.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index55.97 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index169.67 (26.88)
Search Engine Supply Index3.97 (0.95)

This Compound (55.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (25.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (75.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]